Non-TNFi b/tsDMARDs vs. TNFi in Rheumatoid Arthritis-Interstitial Lung Disease: An Active-Comparator, New-User, Propensity Score Matched Study Using National Veterans Affairs Data - ACR Meeting Abstracts
Background/Purpose: There is a paucity of data to guide biologic and JAKi DMARD selection in rheumatoid arthritis-interstitial lung disease (RA-ILD), with some reports of higher mortality with TNFi use in this population (Druce et al. RMD Open, 2017). We performed a real-world pharmacoepidemiologic…
acrabstracts.org